Skip to content

Reference information only. Therapept does not sell peptides and does not provide medical advice.Research-use notice

Therapept

Ask Therapept

Plain-English answers grounded in primary literature

Every answer is composed deterministically from verified scientific records, clinical trials, FDA labeling, and analytical lab data. No language model in the loop, zero synthetic hallucinations, and clear distinctions between human trials and animal models.

Popular questions with verified answers:
Medical Boundary:Therapept is an open-access scientific reference and educational catalog, not a clinic or medical provider. Answers are composed deterministically from verified database records, clinical trials, and FDA labeling. We never provide personal diagnoses, medical treatments, or individualized dosing instructions.
Question AnsweredDeterministic Attributed Record

which compounds have human clinical trials

1

Verified Source-Derived Information

Clinical Trial Hierarchy & Regulatory Classifications·Reviewed: 2026-09-24
  • ✓Therapept indexes 9 FDA-approved therapeutics with completed Phase 1–3 human trial packages.
  • ✓2 investigational compounds are currently undergoing active registered clinical trials.
  • ✓Remaining research peptides (e.g. BPC-157, TB-500) possess preclinical animal models only with zero completed human Phase 3 trials.
Attributed Sources:
2

Educational Explanation & Context

The Plain-English Summary

In Therapept's 32-compound library, 9 compounds are FDA-approved prescription therapeutics, 2 are investigational molecules undergoing registered clinical trials, and the remainder are preclinical research chemicals studied only in cell cultures or animals.

Technical Mechanism & Details

FDA-approved peptides have completed extensive multi-phase human clinical trials demonstrating safety and efficacy for specific medical indications (e.g. Semaglutide for obesity/diabetes, Tesamorelin for HIV visceral lipodystrophy, Teriparatide for osteoporosis). Investigational candidates like Retatrutide and Cagrilintide have completed Phase 2 trials and are in active Phase 3 testing.

Therapept strictly categorizes all compounds into three evidentiary worlds: FDA-Approved Therapeutics, Investigational Drug Candidates, and Preclinical Research Chemicals.

Substances like BPC-157 and TB-500, despite massive internet popularity, have zero completed Phase 3 randomized human clinical trials.

3

Unknown / Not Available & Regulatory Boundaries

No additional evidence gaps recorded for this specific inquiry.

Helpful Follow-Up Questions

Related Guides & References on Therapept

How Ask Therapept Works: Deterministic Transparency

  • •Zero AI Hallucinations: Every answer is synthesized directly from verified database records, published peer-reviewed studies, FDA drug labels, and analytical chemistry testing guides. There is no generative language model fabricating unverified claims.
  • •Source Tier Transparency:Claims follow Therapept’s Level 1–5 evidence hierarchy — official FDA labeling, peer-reviewed research, editorial synthesis, and separated community signals.
  • •Honest Limits: Therapept will not provide personal medical advice, recommend unapproved dosages, or turn forum gossip into facts. When information is unstudied or restricted, Therapept states so clearly.